Your browser doesn't support javascript.
loading
Core-binding factor acute myeloid leukemia: long-term outcome of 70 patients uniformly treated with "7+3".
Begna, K H; Xu, X; Gangat, N; Alkhateeb, H; Patnaik, M M; Al-Kali, A; Elliott, M A; Hogan, W J; Litzow, M R; Hook, C C; Wolanskyj-Spinner, A P; Mangaonkar, A; He, R; Pardanani, A; Shah, M; Ketterling, R P; Tefferi, A.
Afiliação
  • Begna KH; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA. begna.kebede@mayo.edu.
  • Xu X; Division of Hematopathology and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Gangat N; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Alkhateeb H; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Patnaik MM; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Al-Kali A; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Elliott MA; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Hogan WJ; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Litzow MR; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Hook CC; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Wolanskyj-Spinner AP; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Mangaonkar A; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • He R; Division of Hematopathology and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Pardanani A; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Shah M; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
  • Ketterling RP; Division of Hematopathology and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • Tefferi A; Department of Internal Medicine and Division of Hematology, Rochester, MN, USA.
Blood Cancer J ; 12(4): 55, 2022 04 07.
Article em En | MEDLINE | ID: mdl-35393398
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos